TrialJournal of neuro-oncology2013
Phase II open-label study of nintedanib in patients with recurrent glioblastoma multiforme.
Aida Muhic et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
44 papers cite it
this paperpooled ittrialcites it
TrialJournal of neuro-oncology2013
Aida Muhic et al.PubMed ↗Publisher ↗
No numbers read from the abstract.